Viewing Study NCT04987658


Ignite Creation Date: 2025-12-25 @ 12:14 AM
Ignite Modification Date: 2026-02-06 @ 6:29 AM
Study NCT ID: NCT04987658
Status: COMPLETED
Last Update Posted: 2023-11-22
First Post: 2021-07-26
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Study of OLZ/SAM in Pediatric Subjects With Bipolar I Disorder
Sponsor: Alkermes, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Bipolar I Disorder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bipolar I Disorder View
None Olanzapine View
None Samidorphan View
None OLZ/SAM View
None ALKS 3831 View
None Pediatric pharmacokentics View
None LYBALVI View